HSC Business Services Organisation website, https://www.npa.co.uk/information-and-guidance/npa-serious-shortage-protocol-resources/, Keep up to date with our email communications, Under the SSP, when presented with NHS or private prescriptions for. In response to significant ongoing disruption to the supply of fluoxetine 30mg capsules, a Serious Shortage Protocol (SSP) have been issued by the Department of Health and Social Care (DHSC) and these can be accessed on the NHS Business Services Authority (NHSBSA) website. Serious Shortage Protocol (SSP) for fluoxetine 30mg capsules – corresponding guidance on endorsement, prescription charges, remuneration and reimbursement plus Q&A. improving the outcomes of their treatment is the core purpose of In response to significant ongoing disruption to the supply of Fluoxetine 30mg capsules, a Serious Shortage Protocol (SSP) has been issued as of Tuesday 20 October 2020. Community pharmacy contractors and their teams are asked to read the document below in full and to implement the protocol with immediate effect on Thursday 20th March 2020. 7 minutes to read. Introduced with immediate effect on Tuesday (October 20), SSP07 recommends three Fluoxetine 10mg capsules or one Fluoxetine 20mg capsule and one Fluoxetine 10mg capsule in … National Pharmacy Association Ltd (1281757) Authorised and regulated by the Financial Conduct Authority. Information on training events and resources available for you and your team, Written by RichardBuxton on Friday 13th March 2020, Urgent actions required by pharmacy teams. A number of resources have been developed to support pharmacy teams in using these protocols. Report ID: 57064: Drug Identification Number: 02380560: Brand name: MINT-FLUOXETINE: Common or Proper name : Fluoxetine: Company Name: MINT PHARMACEUTICALS INC: Market Status: DORMANT: Active Ingredient(s) FLUOXETINE: Strength(s) 10MG: Dosage form(s) CAPSULE: Route of administration: … Dénomination du médicament. FREE for NPA Members Instant Dentist™ is the first dental wellness platform enabling easy and affordable access to private dental care. Details of medication to be supplied under this SSP Name of medicine (including formulation and strength) to be supplied 1 x fluoxetine 20mg capsule PLUS 1 x fluoxetine 10mg … 3 JAN 2020. SERIOUS SHORTAGE PROTOCOL (SSP) Reference Number: SSP007 This SSP applies to the following medicine: Name of medicine (including strength and formulation) Fluoxetine 30mg capsules Legal category POM 1. Name of SSP \ ref no. Government withdraws first serious shortage protocol for fluoxetine 10mg capsules. SPS for Fluoxetine 10mg shortage (Expiry June 2020) SPS for Haloperadol (Serenace) 500mcg Capsules; Supply Disruption - Ranitidine: All Oral Formulations (Oct 2019) fluoxetine Photo: Flickr user Lis Ferla / CC BY-NC 2.0. Please note: we are experiencing a high volume of calls and emails at the moment, thank you for your patience during this busy time. In response to significant ongoing disruption to the supply of Fluoxetine 10mg tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). 27 Feb, 2020 08:00 AM. Serious Shortage Protocol published for Fluoxetine. No concession has been granted yet and we don’t know whether one will be but, in light of this SSP, our Dispensing and Supply Team will be making a strong case for one to be granted as quickly as possible to provide contractors with some security on the issue of reimbursement. Drug Shortage Report for MINT-FLUOXETINE. Monday to Friday 9am - 5pm Fluoxetine depression pill shortage: Pharmac 'playing with people's lives', pharmacist warns. This webpage contains details of the Serious Shortage Protocols (SSPs) currently in place, including links to relevant guidance. Introduced with immediate effect today, Tuesday 20th October 2020, SSP07 has been developed by clinicians and provides pharmacists with procedures to … Expand all. 25 OCT 2019. If the … (Pharmacy Services only) AJP Staff 06/11/2020. Fidelity Energy is able to offer NPA members a significant price saving on energy bills due to their wide range of suppliers saving you up to 48% on your energy bills. Gain new revenue stream through digital dental consults and new private prescriptions. Endo Ventures (manufacturer) will be out of stock of fluoxetine 10mg tablets from early April until the end of 2020 potentially, due to a manufacturing site transfer. (9am - 6pm & Saturday 9am - 1pm Azacitidine for Injection (Currently in Shortage) The Federal Drug Administration (FDA) recently added the popular antidepressant Zoloft (Sertraline) to the drug shortage list. Olanzapine and Fluoxetine (Symbyax) Capsules Status : Discontinuation »Therapeutic Categories: Psychiatry. Last updated on 2020-01-22 History. This SSP has been varied – the revised end date is now 8 Jan 2021. NPA Services Ltd (303781). The Department of Health and Social care (DHSC) in England and Department of Health in Northern Ireland have advised that following a significant ongoing disruption for fluoxetine capsules 40mg; a Serious Shortage Protocol (SSP) for fluoxetine capsules 40mg has received Ministerial approval. SSP for fluoxetine 30mg capsules 1) Endorsement The contractor must endorse the prescription form, EPS token or Electronic Reimbursement Endorsement Message (EREM) as per Clause 9, Part II of the Drug Tariff. Start and end date Supporting guidance; SSP008 Salazopyrin 500mg EN tablets (PDF:151KB) 20 Oct 20 to 4 Dec 20. Drug Shortage Report for PRIVA-FLUOXETINE. Drug Shortage Report for MINT-FLUOXETINE. For further information on this or any other query, please contact the NPA Pharmacy Services team on 01727 891 800 or email pharmacyservices@npa.co.uk. Report a Drug Shortage | Contact Us | FAQ ... Search by Generic Name or Active Ingredient: Start Over | Back to Search Results. Government issues first serious shortage protocols to combat shortages of fluoxetine. The Therapeutic Goods Administration has recently made a number of updates to the database of medicine shortages and newly approved replacements. Australia is experiencing a critical shortage of key drugs including antidepressants, contraceptives and … Droit d'auteur: les textes sont disponibles sous licence Creative Commons attribution, partage dans les mêmes conditions; d’autres conditions peuvent s’appliquer. Fluoxetine : Manufacturing delays : Date of shortage: Early December 2019 Expected return date: Unknown at present: Last updated: 11th December 2020 : Glycopyrronium bromide & Neostigmine Metisulfate 0.5mg/2.5ml Solution for Injection PA0857/002/001: Glycopyrronium & Neostigmine : Manufacturing delays (multiple countries affected) Date of shortage: Early October 2020 Expected … Fluoxetine 10mg capsules have been higher than the Drug Tariff price and consequently this item was granted a price concession in both January and February 2020. Last updated on 2020-01-27 History. A range of essential products and services handpicked for you. Azacitidine for Injection (Currently in Shortage) December 18, 2020. The Department of Health & Social Care (DHSC) has informed us of extensions to the following Serious Shortage Protocols (SSPs). Head and registered offices: Mallinson House, 38-42 St. Peters Street, St. Albans, AL1 3NP.NPA Copyright ©2021. For more general information about what SSPs are and when they may be used, please visit this webpage. Please read our updated Privacy Policy and Terms of Use for information about which cookies we use and what information we collect on our site. Fluoxetine 20mg capsules x 30 £1.15 (Drug Tariff May 2020) Fluoxetine 40mg capsules x 30 £1.80 (Drug Tariff May 2020) Prescribing data for primary care shows there are around 500 prescriptions per month in Wales for fluoxetine 40mg tablets equating to fewer than one patient per general practice and fewer than one prescription per pharmacy per month on average. In response to significant ongoing disruption to the supply of Fluoxetine 10mg tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Last modified on Fri 7 Aug 2020 16.31 EDT . 3 OCT 2019. Please be aware that we are currently reviewing these resources in-line with recent changes that have been made. The end date for this SSP is now Friday 25th September 2020. SERIOUS SHORTAGE PROTOCOL (SSP) Reference Number: SSP05 This SSP applies to the following medicine: Name of medicine (including strength and formulation) Fluoxetine 10mg tablets Legal category POM 1. 11:09 am on 28 February 2020 . The SSP may be amended or revoked at any time but currently expires on Friday 12th June 2020 – PSNC will update contractors on any changes. October 2020. The Department of Health and Social Care (DH) has issued two Serious Shortage Protocols (SSP) for Fluoxetine 30mg capsules and Salazopyrin EN-Tabs 500mg following persisting supply disruption. Mary Seacole Leadership Programme for Community Pharmacy. PSNC has been monitoring the supply situation and, based on our data, has applied for a concession again this month. The measures have been put in place following news that manufacturing issues have resulted in shortages of some fluoxetine 10mg, 30mg and 40mg capsules. Fluoxetine 40mg capsules The SSP for fluoxetine 40mg capsules is being varied to extend the end date, which was previously 4th September 2020. Fluoxetine 10mg tablets are going out of stock. All of these can be found on the following PSNC website page: Just visiting this site means you are probably performing CPD - record it online at https://www.mygphc.org/signin, To view the CPSC Privacy notice please click the following link: CPSC Privacy notice, Constitution, Governance & Annual Reports, Locally Commissioned Services & Local Information, NHS England & NHS Improvement - South East and Public Health England, Primary Care Support England (PCSE) Services, Mental Health, Resilience & Wellbeing Resources, Disclosure and Barring Service checks (DBS), DDA Support (including Compliance Aids information), COVID-19: Testing Health & Social Care staff, Royal Pharmaceutical Society (RPS) - News updates, Pharmaceutical Services Negotiating Committee (PSNC) - News updates, General Pharmaceutical Council (GPhC) - News updates, National Pharmacy Association (NPA) - News updates, Other Development information & opportunities. If the Department of Health and Social Care (DHSC) decide there is a serious shortage of a specific medicine or appliance, then an SSP may be issued. The SSP provides that the capsule formulation of Fluoxetine may be supplied against prescriptions for Fluoxetine 10mg tablets as follows: The pharmacist must exercise their professional judgement to ensure the alternative product is suitable for the patient. They work harder and smarter to give you expert support and outstanding service. By continuing to use this site, you agree that we may store and access cookies on your device. All community pharmacy teams will receive an email to their shared NHSmail account informing them of this SSP. Written by RichardBuxton on Friday 13th March 2020. the new NHS commissioning system. Coming into effect on Thursday 12th March 2020, SSP05 has been developed by clinicians and provides pharmacists with procedures to follow in providing a suitable alternative product, Fluoxetine 10mg capsules in response to the serious shortage affecting the tablets. NPA professional indemnity insurance will cover NPA members, customers (and the pharmacists they employ/engage) when supplying medicines/appliances under the relevant enabling legislation and the Serious Shortages Protocols (SSPs) which apply. Shortage of antidepressants leads to rationing. Accuracy Checking Pharmacy Technician Programme, Community Pharmacy Consultation Service (CPCS) CPD programme, Community Pharmacist Consultation Service (CPCS), Community Pharmacy Home Delivery Service during the COVID-19 outbreak, Quality Payments - An introduction and what it means for contractors, SSP issue for Fluoxtine 10mg tablets - urgent action required by pharmacy teams, PSNC COVID-19 update 30th December 2020.pdf, Locally Commissioned Services & Information. Veuillez lire attentivement cette notice avant de prendre ce médicament car elle contient des informations importantes pour vous. Summary of recommended actions to prepare for dispensing in accordance with an SSP. For over 50 years Amtico have been designing, innovating and manufacturing flooring that is not only beautiful but flexible, durable and sustainable. 28 Feb 2020. Media enquiries - press@npa.co.uk. Share on Twitter; Share on Facebook; Share via email; Share on Reddit; Share on Linked In; One of the country's common antidepressants is being rationed because of a shortage. Report ID: 92901: Drug Identification Number: 02448408: Brand name: PRIVA-FLUOXETINE: Common or Proper name: FLUOXINE 20MG : Company Name: PHARMAPAR INC: Market Status: MARKETED: Active Ingredient(s) FLUOXETINE: Strength(s) 20MG: Dosage form(s) CAPSULE: Route of administration: ORAL: Packaging … Report ID: 57069: Drug Identification Number: 02380579: Brand name: MINT-FLUOXETINE: Common or Proper name : Fluoxetine: Company Name: MINT PHARMACEUTICALS INC: Market Status: DORMANT: Active Ingredient(s) FLUOXETINE: Strength(s) 20MG: Dosage form(s) CAPSULE: Route of administration: … Salazopyrin EN supporting guidance plus Q&A (PDF: 130KB) SSP007 Fluoxetine 30mg capsules (PDF:144KB) 20 Oct 20 to 22 Dec 20. FLUOXETINE BIOGARAN 20 mg, gélule. We use cookies to help provide you with the best possible online experience. Chlorhydrate de fluoxétine. Share this. PSNC Briefing 036/20: Serious Shortage Protocol (SSP): SSP07 – Fluoxetine 30mg capsules. Urgent actions required by pharmacy teams . All community pharmacies will have received an email from NHS Wales Shared Services Partnership via ENAS to inform them that the SSP has been published on the NHS BSA website. Last updated on 2020-10-13 History. On-Line Consultations – GPC/NHSE Statement 05/05/2020; Expansion of the BMA’s first point of contact support for members with concerns about PPE 27/04/2020; CPR as an AGP – COVID19 27/04/2020; Statement by GPC -Community Nurse Drug Charts 27/04/2020; COVID-19 staff redeployment guidance now published on the BMA website 27/04/2020 Estimated availability end of April 2020 Delay in shipping of the drug: 150 mg. 30’s count (NDC 10370-176-11) On … The NPA has produced a template SOP and guidance resource to support pharmacists and pharmacy teams in ensure compliance with relevant requirements when supplying medicines or appliances under an SSP. Continuously improving the quality of care we give patients and (A copy of that email is available Fri 7 Aug 2020 16.00 EDT. Serious shortage protocol issued for haloperidol. Clock. Teprotumumab-trbw (Currently in Shortage) December 22, 2020. It is acknowledged that pharmacists will be expected to exercise professional judgement to determine the appropriateness of making each supply. Par Pharmaceutical (Revised 04/07/2020) Company Contact Information: 800-828-9393, option 5 then option 2 Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA) 100 mg. 30’s count (NDC 10370-175-11) On backorder.